Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Merchant Capital expands platform with launch of 5 new funds

Wednesday, June 08, 2011
Opalesque Industry Update - Merchant Capital Limited, the financial services division of Merchant House Group plc, is set to launch five new funds on its Dublin-domiciled, UCITS III umbrella structure. Five investment managers from around the world, all specialising in alternative investing, have chosen the Merchant Funds’ platform to launch their first UCITS III-compliant funds.

The new funds, which are due to launch before 1st September 2011, will each have between $25m to $100m of assets under management. The funds will cover a variety of strategies from a US-based Exchange Traded Fund to a Russian Equity Long/Short fund.

The Merchant Funds’ UCITS platform is one of the largest global independent platforms providing investment managers with a seamless and cost-effective vehicle for running their own UCITS III funds, coupled with building a suitable distribution programme. Merchant Capital is also one of the few platforms that employs a pre-trade compliance system due to heightened concerns about funds’ abilities to operate within the UCITS rules.

Merchant Capital Limited, Director of Asset Management, George Cadbury, said: “These new launches reflect the growing popularity of UCITS III compliant products by global investment managers. However, setting up a UCITS III product independently can be an expensive and labour-intensive endeavour and we are seeing more and more interest in our platform solution owing to our reduced costs and quicker time-to-market.”Corporate website: Source
PD

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its